Industrial Tools & Service

Search documents
Enerpac Tool(EPAC) - 2025 Q4 - Earnings Call Presentation
2025-10-16 12:30
Financial Performance in FY25 - Enerpac Tool Group achieved record revenue since its relaunch in 2019 [7] - The company delivered an EBITDA margin of nearly 25% [7] - Adjusted EPS reached $181 [12] - The company returned $69 million of capital to shareholders [7] Revenue Growth in FY25 - Total Enerpac Tool Group revenue grew by 46% to $617 million [9] - Industrial Tools & Service (IT&S) revenue increased by 43% to $596 million [9] - IT&S Product revenue grew by 51% to $479 million [9] - IT&S Service revenue increased by 11% to $117 million [9] - Other revenue (Cortland Biomedical) grew by 148% to $21 million [9] Q4 2025 Results - Net sales for Q4 2025 were $168 million, a 55% increase year-over-year [16] - Adjusted EBITDA for Q4 2025 was $44 million, a 151% increase year-over-year, with an adjusted EBITDA margin of 265% [16] - Adjusted EPS for Q4 2025 was $052, a 40% increase year-over-year [16] FY26 Guidance - The company projects net sales between $635 million and $655 million, with organic growth of approximately 1-4% [25] - Adjusted EBITDA is projected to be between $158 million and $168 million [26] - Adjusted EPS is expected to be between $185 and $200 [26] - Free cash flow is projected to be between $100 million and $110 million [26]
Enerpac Tool(EPAC) - 2025 Q3 - Earnings Call Presentation
2025-06-27 12:03
Financial Performance - Q3 FY25 - Enerpac Tool Group's net sales for Q3 FY25 were $159 million, a 5.5% increase compared to $150 million in Q3 FY24[5] - Organic growth for Enerpac Tool Group was 2.0% in Q3 FY25[5] - Industrial Tools & Service (IT&S) net sales were $153 million in Q3 FY25, up 5.1% from $146 million in Q3 FY24, with organic growth of 1.5%[5] - Adjusted EBITDA was $41 million, a 3% increase year-over-year[12] - Adjusted EPS was $0.51, a 9% increase year-over-year[12] Segment Performance - Q3 FY25 - IT&S Product sales were $124 million, a 5.6% increase with 1.0% organic growth[5] - IT&S Service sales were $29 million, a 3.1% increase with 3.4% organic growth[5] - Other (Cortland Biomedical) sales were $5 million, an 18.7% increase[5] Profitability - Q3 FY25 - Gross margin was 50.4%, a decrease of 140 bps year-over-year[12] - Adjusted SG&A was 25.5% of sales, a decrease of 160 bps year-over-year[12] - Adjusted EBITDA margin was 25.9%, a decrease of 50 bps year-over-year[12] FY25 Guidance - The company expects to deliver towards the lower half of the range on Sales, Adjusted EBITDA, and Free Cash Flow[14] - Net sales are projected to be $610 million to $625 million, with 0-2% organic growth and 3-6% total growth[15] - Adjusted EBITDA is projected to be $150 million to $160 million[15] - Free cash flow is projected to be $85 million to $95 million[15]
Enerpac Tool(EPAC) - 2025 Q2 - Earnings Call Presentation
2025-03-25 14:43
Financial Performance - Q2 FY25 - Enerpac Tool Group's net sales reached $146 million, reflecting a 5.1% increase compared to Q2 FY24[5] - Organic sales growth for Enerpac Tool Group was 50%[5] - Adjusted EBITDA was $34 million, with an adjusted EBITDA margin of 232%[11] - Adjusted EPS stood at $039, an 8% increase year-over-year[11] Segment Performance - Q2 FY25 - Industrial Tools & Service (IT&S) net sales were $141 million, a 4% increase from $135 million in Q2 FY24[5] - IT&S Product sales increased by 5% to $114 million[5] - IT&S Service sales increased by 2% to $27 million[5] - Other sales (Cortland Biomedical) increased by 331% to $5 million[5] Liquidity and Capital Allocation - The company maintains strong liquidity with $120 million in cash and equivalents[12] - Undrawn revolver capacity is $399 million, resulting in total liquidity of $518 million[12] - Total debt is $192 million, with a net debt to adjusted EBITDA ratio of 05x[12] FY25 Guidance - The company projects net sales between $610 million and $625 million, with organic growth of approximately 0-2% and total growth of approximately 3-6%[27] - Adjusted EBITDA is expected to be in the range of $150 million to $160 million[27] - Free cash flow is projected to be between $85 million and $95 million[27]